These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10393897)

  • 41. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM.
    Smith AL; Barthold SW; de Souza MS; Bottomly K
    Arch Virol; 1991; 121(1-4):89-100. PubMed ID: 1662041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein.
    Chua MM; Phillips JJ; Seo SH; Lavi E; Weiss SR
    Adv Exp Med Biol; 2001; 494():121-5. PubMed ID: 11774455
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of antigenic peptides derived from B-cell epitopes of nucleocapsid protein of mouse hepatitis virus for serological diagnosis.
    Asano A; Torigoe D; Sasaki N; Agui T
    J Virol Methods; 2011 Oct; 177(1):107-11. PubMed ID: 21810445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1988; 100(3-4):171-83. PubMed ID: 2840871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression.
    Yokomori K; Asanaka M; Stohlman SA; Makino S; Shubin RA; Gilmore W; Weiner LP; Wang FI; Lai MM
    J Neurovirol; 1995 Dec; 1(5-6):330-9. PubMed ID: 9222375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.
    Smith ML; Lindbo JA; Dillard-Telm S; Brosio PM; Lasnik AB; McCormick AA; Nguyen LV; Palmer KE
    Virology; 2006 May; 348(2):475-88. PubMed ID: 16466765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
    Shim BS; Stadler K; Nguyen HH; Yun CH; Kim DW; Chang J; Czerkinsky C; Song MK
    Virol J; 2012 Sep; 9():215. PubMed ID: 22995185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo.
    Smith AL; Cardellichio CB; Winograd DF; de Souza MS; Barthold SW; Holmes KV
    J Infect Dis; 1991 Apr; 163(4):879-82. PubMed ID: 1849166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.
    Bergmann C; McMillan M; Stohlman S
    J Virol; 1993 Dec; 67(12):7041-9. PubMed ID: 7693965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.
    Mebatsion T; Koolen MJ; de Vaan LT; de Haas N; Braber M; Römer-Oberdörfer A; van den Elzen P; van der Marel P
    J Virol; 2002 Oct; 76(20):10138-46. PubMed ID: 12239288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MHV-resistant SJL/J mice express a non-functional homolog to the MHV receptor glycoprotein.
    Williams RK; Snyder SW; Holmes KV
    Adv Exp Med Biol; 1990; 276():45-50. PubMed ID: 1966437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa.
    Staczek J; Bendahmane M; Gilleland LB; Beachy RN; Gilleland HE
    Vaccine; 2000 Apr; 18(21):2266-74. PubMed ID: 10717347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary structures of hemagglutinin-esterase and spike glycoproteins of murine coronavirus DVIM.
    Morita E; Ebina H; Muto A; Himeno H; Hatakeyama K; Sugiyama K
    Virus Genes; 1998; 17(2):123-8. PubMed ID: 9857985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59.
    Daniel C; Talbot PJ
    Virology; 1990 Jan; 174(1):87-94. PubMed ID: 2152996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
    Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
    J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine prediction algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically influenced by the nature of the protein carrier.
    Daniel C; Lacroix M; Talbot PJ
    Virology; 1994 Aug; 202(2):540-9. PubMed ID: 8030220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Passively acquired challenge immunity to enterotropic coronavirus in mice.
    Homberger FR; Barthold SW
    Arch Virol; 1992; 126(1-4):35-43. PubMed ID: 1326267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunogenicity of S1 gene DNA vaccine of mouse hepatitis virus delivered by attenuated Salmonella typhimurium].
    Jiao HM; Jiao XA; Yin YL; Pan ZM; Meng SS; Wang Y; Jiang JJ
    Wei Sheng Wu Xue Bao; 2007 Feb; 47(1):131-5. PubMed ID: 17436639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.